These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6324780)

  • 41. Evidence for the occurrence of calmodulin in the yeasts Candida albicans and Saccharomyces cerevisiae.
    Hubbard M; Bradley M; Sullivan P; Shepherd M; Forrester I
    FEBS Lett; 1982 Jan; 137(1):85-8. PubMed ID: 6121717
    [No Abstract]   [Full Text] [Related]  

  • 42. [Effect of pH on Ca-binding properties of calmodulin and on its interaction with Ca-dependent phosphodiesterase of cyclic nucleotides].
    Tkachuk VA; Men'shikov MIu
    Biokhimiia; 1981 Jun; 46(6):963-73. PubMed ID: 6266519
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Characteristics of cyclic nucleotide phosphodiesterase and calmodulin in the small intestinal mucosa of rabbits].
    Iurkov VA
    Biull Eksp Biol Med; 1981 Jul; 92(7):91-4. PubMed ID: 6271290
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Calmodulin and alpha tocopherol as additional binding sites for doxorubicin.
    Nwankwoala RN; West WL
    Cancer Chemother Pharmacol; 1986; 16(2):133-8. PubMed ID: 3004771
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Benzylisoquinoline compounds inhibit the ability of calmodulin to activate cyclic nucleotide phosphodiesterase.
    Hu ZY; Chen SL; Hao ZG; Huang WL; Peng SX
    Cell Signal; 1989; 1(2):181-5. PubMed ID: 2561985
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of Mg2+-binding sites and the role of Mg2+ on target recognition by calmodulin.
    Ohki S; Ikura M; Zhang M
    Biochemistry; 1997 Apr; 36(14):4309-16. PubMed ID: 9100027
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Interaction of tertiapin, a neurotoxin from bee venom, with calmodulin].
    Miroshnikov AI; Boĭkov VA; Snezhkova LG; Severin SE; Shvets VI
    Bioorg Khim; 1983 Jan; 9(1):26-32. PubMed ID: 6091685
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Calmodulin fragments can not activate target enzymes.
    Minowa O; Yazawa M; Sobue K; Ito K; Yagi K
    J Biochem; 1988 Mar; 103(3):531-6. PubMed ID: 2839470
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 1H-NMR studies of calmodulin: the character of the calcium binding sites.
    Sutoo D; Akiyama K; Fujii N; Matsushita K
    Jpn J Pharmacol; 1989 Jun; 50(2):217-27. PubMed ID: 2770057
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Isolation and properties of 2 forms of cyclic nucleotide phosphodiesterase from the rat brain under normal conditions and after irradiation].
    Parkhomets TI; Vasil'ev AN; Chernen'kaia SN; Kucherenko NE
    Ukr Biokhim Zh (1978); 1985; 57(3):31-5. PubMed ID: 2992140
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mechanism of activation of cyclic nucleotide phosphodiesterase: requirement of the binding of four Ca2+ to calmodulin for activation.
    Huang CY; Chau V; Chock PB; Wang JH; Sharma RK
    Proc Natl Acad Sci U S A; 1981 Feb; 78(2):871-4. PubMed ID: 6262778
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aluminum interaction with calmodulin. Evidence for altered structure and function from optical and enzymatic studies.
    Siegel N; Haug A
    Biochim Biophys Acta; 1983 Apr; 744(1):36-45. PubMed ID: 6299365
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of site-directed mutations in the individual Ca2(+)-binding sites of calmodulin to examine Ca2(+)-induced conformational changes.
    Beckingham K
    J Biol Chem; 1991 Apr; 266(10):6027-30. PubMed ID: 1901056
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An endogenous Ca2+-dependent activator protein of brain adenylate cyclase and cyclic neucleotide phosphodiesterase.
    Cheung WY; Lynch TJ; Wallace RW
    Adv Cyclic Nucleotide Res; 1978; 9():233-51. PubMed ID: 208377
    [No Abstract]   [Full Text] [Related]  

  • 55. Monovalent cation-insensitive hydrophobic region on calmodulin facilitates the rapid isolation and quantitation of calmodulin free from other Ca2+-dependent hydrophobic proteins.
    Gopalakrishna R; Anderson WB
    J Appl Biochem; 1985; 7(4-5):311-22. PubMed ID: 3005224
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 9-(Dicyanovinyl)julolidine binding to bovine brain calmodulin.
    Iio T; Itakura M; Takahashi S; Sawada S
    J Biochem; 1991 Apr; 109(4):499-502. PubMed ID: 1869503
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Temperature dependent conformational changes in calmodulin.
    Gangola P; Pant HC
    Biochem Biophys Res Commun; 1983 Feb; 111(1):301-5. PubMed ID: 6830594
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The kinetics of calcium binding to calmodulin: Quin 2 and ANS stopped-flow fluorescence studies.
    Bayley P; Ahlström P; Martin SR; Forsen S
    Biochem Biophys Res Commun; 1984 Apr; 120(1):185-91. PubMed ID: 6712688
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sequential events in calmodulin on binding with calcium and interaction with target enzymes.
    Cox JA
    Fed Proc; 1984 Dec; 43(15):3000-4. PubMed ID: 6500074
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activation of calmodulin by various metal cations as a function of ionic radius.
    Chao SH; Suzuki Y; Zysk JR; Cheung WY
    Mol Pharmacol; 1984 Jul; 26(1):75-82. PubMed ID: 6087119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.